SNRPCP5

Across TCGA pan-cancer cohorts, SNRPCP5 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SNRPCP5’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where SNRPCP5 RNA is repressed in tumor relative to normal tissue. In most cancer types SNRPCP5 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA and KIRC are the cancer types where SNRPCP5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNRPCP5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.240	<.001	6	view →
KIRC	Male	All	+0.108	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

SNRPCP5–THCA

Open the THCA breakdown →